Compare IDXX & FMX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | IDXX | FMX |
|---|---|---|
| Founded | 1983 | 1890 |
| Country | United States | Mexico |
| Employees | N/A | N/A |
| Industry | Biotechnology: In Vitro & In Vivo Diagnostic Substances | Beverages (Production/Distribution) |
| Sector | Health Care | Consumer Staples |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 45.4B | 41.4B |
| IPO Year | 1996 | 1998 |
| Metric | IDXX | FMX |
|---|---|---|
| Price | $568.57 | $125.36 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 14 | 15 |
| Target Price | ★ $698.00 | $134.86 |
| AVG Volume (30 Days) | 463.3K | ★ 528.4K |
| Earning Date | 11-02-2026 | 10-28-2026 |
| Dividend Yield | N/A | ★ 5.21% |
| EPS Growth | ★ 22.59 | N/A |
| EPS | ★ 7.74 | N/A |
| Revenue | ★ $4,303,702,000.00 | N/A |
| Revenue This Year | $9.78 | $7.68 |
| Revenue Next Year | $8.90 | $7.72 |
| P/E Ratio | $72.66 | ★ $40.94 |
| Revenue Growth | ★ 10.42 | N/A |
| 52 Week Low | $500.61 | $90.87 |
| 52 Week High | $769.98 | $141.47 |
| Indicator | IDXX | FMX |
|---|---|---|
| Relative Strength Index (RSI) | 65.41 | 56.59 |
| Support Level | $562.96 | $121.06 |
| Resistance Level | $581.28 | $131.18 |
| Average True Range (ATR) | 11.41 | 2.76 |
| MACD | 4.88 | 0.77 |
| Stochastic Oscillator | 97.12 | 63.57 |
Idexx Laboratories primarily develops, manufactures, and distributes diagnostic products, equipment, and services for pets and livestock. Its key product lines include single-use canine and feline test kits that veterinarians can employ in the office, benchtop chemistry and hematology analyzers for test-panel analysis on-site, reference lab services, and tests to detect and manage disease in livestock. The firm also offers vet practice management software and consulting services to animal hospitals. Idexx derives roughly 35% of its revenue from outside the United States.
Mexico-based Femsa is a beverage and retail conglomerate in Central and South America. The holding company owns controlling stakes in bottler Coca-Cola Femsa (47% economic stake, 56% voting rights), in addition to operating 100%-owned retail assets, including convenience stores under the Oxxo banner, drugstores, and gas stations. The firm divested its 15% stake in Heineken and its distribution business in 2023. Coca-Cola Femsa and the Oxxo chain made up over 70% of total company revenue and over 90% of profits in 2025.